Tradestie Institutional Equity Comparison Engine

KURA vs CRMD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CRMD Overall Edge

CRMD Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CorMedix Inc. (CRMD) driven by superior Valuation, Growth & Margin while KURA counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, KURA trades at N/M Forward P/E with -394.3% operating margin (+10.1% YoY revenue) versus CRMD at 49.0x Forward P/E and 41.0% operating margin (-47.7% YoY). In options structure, KURA sits in BREAKDOWN (20th %ile IV; Dealer Gamma Walls on Pro) against CRMD sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CRMD
KURA N/M vs CRMD 49.0x Fwd P/E
Growth & Margin Winner CRMD
Op Margin -394.3% vs 41.0% ยท YoY +10.1% vs -47.7%
Momentum & Technical Winner KURA
1Y -31.6% vs -56.2% ยท 52W Pos 8% vs 3%
Options & Structure Winner KURA
BREAKDOWN (20th %ile IV) vs BREAKDOWN (25th %ile IV)
KURA NASDAQ
Kura Oncology, Inc.
Pharmaceutical Preparations
$7.30
-6.05% 1D
Market Cap $690.9M
1M Return -19.6%
1Y Return -31.65%
Forward P/E N/M
Unified AI Score
64.1 / 100 BUY
Tech 63.0 Fund 64.0 Flow 67.0 Mom 60.0
CRMD NASDAQ
CorMedix Inc.
Pharmaceutical Preparations
$4.92
+5.47% 1D
Market Cap $384.7M
1M Return -32.3%
1Y Return -56.16%
Forward P/E 49.0x
Unified AI Score
53.2 / 100 HOLD
Tech 60.0 Fund 60.0 Flow 69.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: KURA -31.65% CRMD -56.16% Spread: +24.51 pp (KURA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period KURA Revenue CRMD Revenue KURA Op. Margin CRMD Op. Margin Margin Edge
FY2017 N/A $0M N/A -9997.4% CRMD
FY2018 N/A $0M N/A -6250.4% CRMD
FY2019 N/A $0M N/A -7416.3% CRMD
FY2020 N/A $0M N/A -11378.4% CRMD
FY2021 N/A $0M N/A -15417.5% CRMD
FY2022 N/A $0M N/A -46819.9% CRMD
FY2024 $50M $40M -358.5% -51.4% CRMD
FY2025 $70M $310M -449.9% 48.2% CRMD

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: KURA (4) vs CRMD (6)
Institutional Metric KURA CRMD Criterion Row Winner
Market Capitalization Scale $690.9M $384.7M Larger Scale KURA
Trailing P/E Ratio Valuation N/M 2.4x Lower Multiple CRMD
Forward P/E Ratio Valuation N/M 49.0x Lower Multiple CRMD
Revenue Growth (YoY) Growth +10.1% -47.7% Higher Growth KURA
Operating Margin (TTM) Profitability -394.3% 41.0% Higher Margin CRMD
Net Profit Margin Profitability 0.0% 15.5% Higher Margin CRMD
Return on Equity (ROE) Capital Efficiency -224.8% 15.3% Higher ROE CRMD
52-Week Range Position Momentum 8% ($7โ€“$14) 3% ($5โ€“$13) Stronger Trend KURA
Beta / 30D Volatility Risk Regime 1.42ฮฒ ยท 108% Vol 1.20ฮฒ ยท 107% Vol Lower Realized Risk CRMD
Unified Institutional Score Composite Signal 64.1 / 100 (BUY) 53.2 / 100 (HOLD) Higher Composite KURA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full KURA vs CRMD Buy Guide
KURA BREAKDOWN
58d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 20th %ile
IV Regime Compressed (<25th %ile)
Live KURA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CRMD BREAKDOWN
109d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Compressed (<25th %ile)
Live CRMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither KURA nor CRMD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.